These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [The future of vaccines: recombinant DNA vaccines]. van Dam RH; Keus RJ Tijdschr Diergeneeskd; 1990 May; 115(9):413-9. PubMed ID: 2188394 [TBL] [Abstract][Full Text] [Related]
23. [Improvement of veterinary vaccines through the use of new adjuvants]. Hilgers LA Tijdschr Diergeneeskd; 1991 May; 116(10):508-12. PubMed ID: 2048061 [TBL] [Abstract][Full Text] [Related]
24. Application of new vaccine technologies for the control of transboundary diseases. Swayne DE Dev Biol (Basel); 2004; 119():219-28. PubMed ID: 15742632 [TBL] [Abstract][Full Text] [Related]
25. The future of respiratory syncytial virus vaccine development. Polack FP; Karron RA Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S65-73. PubMed ID: 14730272 [TBL] [Abstract][Full Text] [Related]
26. [Research and development strategies, examples among new vaccines]. Denis F; Ploy MC Ann Pharm Fr; 2009 May; 67(3):198-202. PubMed ID: 19446670 [TBL] [Abstract][Full Text] [Related]
27. [Preparation of vaccines]. Ruitenberg EJ Tijdschr Diergeneeskd; 1990 Apr; 115(8):362-70. PubMed ID: 2186504 [TBL] [Abstract][Full Text] [Related]
28. Vaccination against equine influenza: quid novi? Paillot R; Hannant D; Kydd JH; Daly JM Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507 [TBL] [Abstract][Full Text] [Related]
29. Clinical experience with inactivated, virosomal influenza vaccine. de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120 [TBL] [Abstract][Full Text] [Related]
30. New Principles of Development of Preparations for Immunoprophylaxis. Vorobyev AA; Medunitsyn NV Russ J Immunol; 1999 Dec; 4(4):352-354. PubMed ID: 12687155 [TBL] [Abstract][Full Text] [Related]
31. Tuberculosis: looking beyond BCG vaccines. Mustafa Abu S; Al-Attiyah R J Postgrad Med; 2003; 49(2):134-40. PubMed ID: 12867689 [TBL] [Abstract][Full Text] [Related]
33. Development of improved attenuated and nucleic acid vaccines for heartwater. Collins NE; Pretorius A; van Kleef M; Brayton KA; Allsopp MT; Zweygarth E; Allsopp BA Dev Biol (Basel); 2003; 114():121-36. PubMed ID: 14677683 [TBL] [Abstract][Full Text] [Related]
34. [On three revolutions of vaccine]. Kou Y Zhonghua Yi Shi Za Zhi; 2006 Apr; 36(2):104-8. PubMed ID: 17096989 [TBL] [Abstract][Full Text] [Related]
35. Combined vaccines--the European contribution. Glück R Biologicals; 1994 Dec; 22(4):347-51. PubMed ID: 7779361 [TBL] [Abstract][Full Text] [Related]
36. Recombinant DNA technology for producing new rinderpest virus vaccines. Barrett T Expert Rev Vaccines; 2005 Feb; 4(1):113-20. PubMed ID: 15757478 [TBL] [Abstract][Full Text] [Related]
38. New generation smallpox vaccines: a review of preclinical and clinical data. Artenstein AW Rev Med Virol; 2008; 18(4):217-31. PubMed ID: 18283712 [TBL] [Abstract][Full Text] [Related]
39. Recent developments in veterinary vaccinology. Shams H Vet J; 2005 Nov; 170(3):289-99. PubMed ID: 16266843 [TBL] [Abstract][Full Text] [Related]